Fri Oct 31 13:22:19 SGT 2014  
SINGAPORE
BOTOX™
    Botox® jaw reduction, Singapore (SG)

Botox® jaw reduction, Singapore (SG)

Summary

Botox® jaw reduction, Singapore (SG) @singaporebotox_com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, Singapore. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.

Description

Jaw slimming / face slimming / Botox® jaw reduction / Botox® jaw slimming / Botox® face slimming price.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Jaw reduction8 to 12656SG$840
ConsultationSG$38
TotalSG$878

Botox® price. Average Botox® cost.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Horizontal forehead lines2816SG$240
Glabellar frown lines4520SG$300
Crow's feet4624SG$360
ConsultationSG$38
TotalSG$938

Botox® is one of the trade names for botulinum toxin, which is a protein produced by the bacterium clostridium botulinum.

Botox® treatment is with the original Allergan Botox® Cosmetic

  • The units differ for different brands.
  • Price quoted is for average ladies face, with average musculature.
  • Muscular men might require up to twice as much.
  • Minimum charge is for 10 units.

Aesthetic services available:

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Botox® jaw reduction, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Anatomical Considerations Regarding the Location and Boundary of the Depressor Anguli Oris Muscle with Reference to Botulinum Toxin Injection
Wed, 29 Oct 2014 15:51:35 +0100 | Plastic and Reconstructive Surgery
Conclusion: These results suggest that the fan-shaped area bounded by LP2, LP3, and the mandibular border is the safest and most effective depressor anguli oris muscle injection site. (Source: Plastic and Reconstructive Surgery)

Saatchi bill debated in Lords
Fri, 24 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
The bill to allow doctors to use experimental treatments with seriously ill people has been debated in the House of Lords. Reports highlight comments in favour by Lord Blencathra (who has MS) and against by Lord Winston. Lord Blencathra refers to his own use of an innovative treatment (presumably as part of the clinical trials) with botulinum toxin.

Long-term stability of mandibular ramus elongation in severe facial asymmetry
Fri, 24 Oct 2014 04:12:49 +0100 | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
The purpose of this report is to present adjunctive use of botulinum toxin A (Botox) in lengthening the pterygomasseteric sling when correcting hemimandibular hyperplasia. We present the surgical management of a case of severe facial asymmetry with orthognathic surgery using 3-dimensional models in treatment planning and Botox as adjunct therapy. (Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics)

Cosmetic Surgery Poll
Thu, 23 Oct 2014 16:34:26 +0100 | Telegraph Health
Following Renee Zellweger's new fresh-faced look, complete our survey on cosmetic procedures (Source: Telegraph Health)

Valeant says may raise Allergan bid; beats on profit
Mon, 20 Oct 2014 16:50:40 +0100 | Reuters: Health
(Reuters) - Valeant Pharmaceuticals International Inc VRX.TO VRX.N said on Monday that it may raise its bid for Botox maker Allergan Inc AGN.N after the Canadian company posted a better-than-expected quarterly profit. (Source: Reuters: Health)

Valeant reports better-than-expected profit, raises forecast
Mon, 20 Oct 2014 12:12:23 +0100 | Reuters: Health
(Reuters) - Canada's Valeant Pharmaceuticals International Inc , embroiled in a bitter fight to take over Botox maker Allergan Inc , posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs. (Source: Reuters: Health)

Eyes watering all the time? You may need a Botox jab 
Tue, 14 Oct 2014 00:12:07 +0100 | the Mail online | Health
Watering eyes are normally due to a problem with the drainage of tears, which help lubricate the eye, protecting it from damage and keeping it healthy. (Source: the Mail online | Health)

False vocal cord botulinum toxin injection for refractory muscle tension dysphonia: Our experience with 7 patients
Tue, 14 Oct 2014 00:00:00 +0100 | Clinical Otolaryngology
ConclusionFVC Botox offers benefit to patients with refractory MTD. Best results are obtained with continued voice therapy following injection.This article is protected by copyright. All rights reserved. (Source: Clinical Otolaryngology)

Transurethral Intraprostatic Injection of Botulinum Toxin Type A for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results of a Prospective Pilot Double‐Blind and Randomized Placebo‐Controlled study
Mon, 13 Oct 2014 00:00:00 +0100 | BJU International
ConclusionsTransurethral intraprostatic BoNT‐A injection may be an effective therapeutic option in CP/CPPS patients by reducing pain and improving QoL. (Source: BJU International)

OnabotulinumtoxinA and multiple sclerosis
Sun, 12 Oct 2014 00:00:00 +0100 | Annals of Physical and Rehabilitation Medicine
Publication date: July 2014 Source:Annals of Physical and Rehabilitation Medicine, Volume 57, Issue 5 Author(s): B. Schurch , S. Carda Lower urinary tract dysfunction is present in two of three patients with multiple sclerosis five years after the diagnosis. Most frequent symptoms are related to neurogenic detrusor overactivity, often associated with detrusor-sphincter dyssynergia. From the end of the 1990s, there is growing evidence that neurogenic detrusor overactivity can be effectively managed by intradetrusorial injections of botulinum toxin type A. This treatment has shown, in different randomised placebo-controlled trials, to be safe and effective on clinical and urodynamic parameters with significant improvement in quality of life. The median duration of effect is in mean nine mo...